Lake Street Upgrades Tandem Diabetes Care to Buy, Announces $50 Price Target
Benzinga Newsdesk 8 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Lake Street analyst Frank Takkinen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold to Buy and announces $50 price target.
Lake Street analyst Frank Takkinen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold to Buy and announces $50 price target.